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Abstract
Itch is a sensation that promotes the desire to scratch, which can be evoked by mechanical and chemical stimuli. In the spinal
cord, neurons expressing the gastrin-releasing peptide receptor (GRPR) have been identified as specific mediators of itch.
However, our understanding of the GRPR population in the spinal cord, and thus how these neurons exercise their functions, is
limited. For this purpose, we constructed a Cre line designed to target the GRPR population of neurons (Grpr-Cre). Our analysis
revealed that Grpr-Cre cells in the spinal cord are predominantly excitatory interneurons that are found in the dorsal lamina,
especially in laminae II-IV. Application of the specific agonist gastrin-releasing peptide induced spike responses in 43.3% of the
patched Grpr-Cre neurons, where the majority of the cells displayed a tonic firing property. Additionally, our analysis showed that
the Grpr-Cre population expresses Vglut2 mRNA, and mice ablated of Vglut2 in Grpr-Cre cells (Vglut2-lox;Grpr-Cre mice)
displayed less spontaneous itch and attenuated responses to both histaminergic and nonhistaminergic agents. We could also
show that application of the itch-inducing peptide, natriuretic polypeptide B, induces calcium influx in a subpopulation of Grpr-
Cre neurons. To summarize, our data indicate that the Grpr-Cre spinal cord neural population is composed of interneurons that
use VGLUT2-mediated signaling for transmitting chemical and spontaneous itch stimuli to the next, currently unknown, neurons
in the labeled line of itch.
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1. Introduction
Itch, or pruritus, is a sensory modality that functions to remove
potentially harmful pathogens. Although itch is most commonly
associatedwith an acute state, for example, after amosquito bite,
itch can also exist in persistent forms in diseases, such as atopic
dermatitis, urticaria, prurigo nodularis, and psoriasis. Pruritic
substances are sensed by primary afferent neurons, or pruri-
ceptors, which express a variety of receptors specifically devoted
to the detection of endogenous and exogenous itch-inducing
agents such as histamine or chloroquine.16,26,28 The pruriceptive
neurons are confined within the slowly conducting C-fibers and
the thinly myelinated Ad fibers, with their cell bodies in the dorsal
root ganglia (DRG) and free nerve endings innervating the
skin.15,23,26 Once activated, pruriceptors convey the information
to the spinal cord dorsal horn via neuropeptide natriuretic
polypeptide B (NPPB)17 and calcitonin gene–related peptide,24
where the information is projected further via spinothalamic tract
neurons to the brain for interpretation.1 Although our knowledge
about the initiation and transmission of pruritic signaling in the
periphery has increased in the last couple of years, less is known
about the central transmission of itch in the spinal cord.
The gastrin-releasing peptide receptor (GRPR) is a G-
protein-coupled receptor expressed in the superficial layers
of the dorsal horn.10,30 Grpr knockout analysis has shown that
GRPR is not involved in any pain modalities tested (thermal,
mechanical, inflammatory, and neuropathic pain).30 Intrader-
mal injection of histamine and nonhistaminergic agents in Grpr
knockout mice or gastrin-releasing peptide (GRP)-saporin–
treated mice, however, led to a significant reduction in
scratching, suggesting that GRPR and the GRPR-expressing
neurons are mediators of both histamine-dependent and
independent itch.30,31 Still, little is known about the intrinsic
properties of the spinal cord GRPR population. Here, we
generated a Grpr-Cre mouse line using a bacterial artificial
chromosome (BAC) cloning strategy to specifically label and
manipulate the Grpr-Cre subpopulation of neurons, allowing
us to reveal their inherent properties and to determine their
position in the labeled line of itch.
Sponsorships or competing interests that may be relevant to content are disclosed
at the end of this article.
Departments of a Neuroscience and, b Medical Cell Biology, Uppsala University,
Uppsala, Sweden
*Corresponding author. Address: Department of Neuroscience, Uppsala University,
Box 593, 751 24, Uppsala, Sweden. Tel.: 146184714513. E-mail address:
Malin.Lagerstrom@neuro.uu.se (M. C. Lagerstro¨m).
Supplemental digital content is available for this article. Direct URL citations appear
in the printed text and are provided in the HTML and PDF versions of this article on
the journal’s Web site (www.painjournalonline.com).
PAIN 158 (2017) 945–961
Copyright© 2017 The Author(s). Published byWolters Kluwer Health, Inc. on behalf
of the International Association for the Study of Pain. This is an open-access article
distributed under the terms of the Creative Commons Attribution-Non Commercial-
No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and
share the work provided it is properly cited. The work cannot be changed in any way
or used commercially without permission from the journal.
http://dx.doi.org/10.1097/j.pain.0000000000000861
May 2017·Volume 158·Number 5 www.painjournalonline.com 945
2. Materials and methods
2.1. Generation of Grpr-Cre mice
TheGrpr-Cre linewasgeneratedusingaBACcloning strategybased
onhttp://recombineering.ncifcrf.gov/protocol/Protocol1_DY380.pdf.
Briefly, the BAC RP23-395E7 (BACPAC Resources) consisting of
a 189 kbp fragment, including the Grpr gene, was transferred to
electrocompetent and recombination-induced EL250 cells by
electroporation. These cells were plated on chloramphenicol
(25 mg/mL; Fisher Scientific, Go¨teborg, Sweden) plates and positive
colonies were controlled for BAC insertion using colony PCR and
pulsed-field gel electrophoresis (CHEF Mapper; Bio-Rad, Solna,
Sweden). A codon-improved Cre coding sequence together with an
ampicillin cassette flanked by frt sites was inserted to replace exon 1
in the Grpr gene, and the cells were streaked onto plates with both
chloramphenicol and ampicillin (100 mg/mL; Sigma, Stockholm,
Sweden). Positive Cre-containing colonies were picked and treated
with 10%arabinose (Sigma) to remove theampicillin cassette. Finally,
DNA from one of these colonies was purified using a Qiagen
purification kit (large construct kit 10; Qiagen, Sollentuna, Sweden).
The DNA sample was digested with NotI (Fermentas, Stockholm,
Sweden) and run through a column (GE Healthcare, Uppsala,
Sweden) to separate the vector from the desired DNA fragment.
Thereafter, the purified DNA was sent for pronuclear injection at the
Karolinska Center for Transgene Technologies (KCTT). Every
subcloning stage was verified by PCR and pulsed-field gel
electrophoresis. The primers used for wild type (Grpr) identification
were 59-cctggaagggattgtgagtt-39 (forward) and 59-cagcaag-
tacctggctgaca-39 (reverse) with a product size of 237 bp. The
primers used for Cre identification were 59-cctggaagggattgtgagtt-39
(forward) and 59-cgctgagataggtgcctcac-39 (reverse) with a product
size of 234 bp. Before verification with gel electrophoresis, the DNA
plasmid was digested with the enzyme NotI and the following
fragment sizes were obtained: for the Grpr gene 180.013 kbp and
8734 bp, forCre 112.332 bp, 69.982 bp, and 8734 bp, andCre after
arabinose treatment 181.152 kbp and 8734 bp.
2.2. Animals
All animal procedureswere approvedby the local ethical committee in
Uppsala and followed the Directive 2010/63/EU of the European
Parliament and of the Council, The Swedish Animal Welfare Act
(Djurskyddslagen: SFS 1988:534), The Swedish Animal Welfare
Ordinance (Djurskyddsfo¨rordningen: SFS 1988:539), and the provi-
sions regarding the use of animals for scientific purposes: DFS 2004:
15 and SJVFS 2012:26. Both female and male mice were used.
Founders carrying Grpr-Cre were crossed with the reporter line
tdTomato (Gt(ROSA)26Sortm14(CAG-tdTomato)Hze; Allen Brain Institute),
Viaat-egfp (GENSAT, MMRRC), or Vglut2f/f mice.33 Offspring were
genotyped for the presence of the Grpr-Cre allele, the tdTomato
allele, theViaat-egfpallele, and theVglut2allele. The followingprimers
were used:Grpr-Cre59-gtgcaagctgaacaacagga-39 (forward) and59-
ccagcatccacattctcctt-39 (reverse); tdTomato 59-tgttcctgtacggcatgg-
39 (forward, mutant allele), 59-ggcattaaagcagcgtatcc-39 (reverse,
mutant allele), 59-aagggagctgcgtggagta-39 (forward, wild type allele),
59-ccgaaaatctgtgggaagtc-39 (reverse, wild type allele); Viaat-egfp
59-gacgtaaacggccacaagttc-39 (forward, mutant allele), 59-
cttctcgttggggtctttgct-39 (reverse, mutant allele); and Vglut2f/f 59-
caggcaaaatctgtccacct-39 (forward), 59-agggtaggccaaaagcaatc-39
(reverse). The Grpr-Cre allele was kept heterozygous.
2.3. Tissue preparation
Adult (.7 weeks) and P4 mice were anaesthetized by in-
traperitoneal injection of a mixture of 0.5 mg/mL ketamine
hydrochloride (Ketaminol; Pfizer) and 0.5 mg/mL medetomidine
hydrochloride (Domitor; Orion Pharma, Sollentuna, Sweden). The
skin around the sternum as well as the diaphragm was cut and
thereafter the veins below the liver and above the heart.
Phosphate-buffered saline (Gibco Life Technologies) was
pumped into the heart to remove the blood, before running 4%
formaldehyde (HistoLab, Go¨teborg, Sweden) through the body.
The brain (P4) and spinal cord (.7 weeks) were removed,
postfixed in 4% formaldehyde, and run through a gradient of
10%, 20%, and 30% sucrose solutions (Sigma) before embed-
ding in O.C.T compound (Sakura Finetek, Go¨teborg, Sweden) at
280˚C. The spinal cord and brain were cut at a thickness of 14
and 16 mm, respectively, for immunohistochemical analysis.
2.4. Immunohistochemistry
Spinal cord and brain sections were rinsed in 13 tris-buffered
saline (TBS), followed by incubation overnight at 4˚C with primary
antibodies diluted in blocking solution containing 0.5% gelatin
(Bio-Rad) and 0.01% triton-X (Sigma-Aldrich) in 13TBS. The
following day, the sections were rinsed once again in 13TBS
before incubation at room temperature for 1.5 hours with the
secondary antibodies. Before mounting the slides, the tissue was
rinsed repeatedly in 13TBS. The primary antibodies used were
mouse monoclonal anti-NeuN 1:400 (Millipore, Solna, Sweden),
chicken anti–green fluorescent protein 1:1000 (Abcam, Cam-
bridge, United Kingdom), and rabbit anti-Pax2 1:200 (Biolegend,
San Diego, CA). The secondary antibodies used were goat anti-
chicken Alexa 647 1:200 (Invitrogen), donkey anti-mouse Alexa
488 1:400 (Invitrogen), and donkey anti-rabbit Alexa 647 1:400
(Invitrogen). IB4 was diluted 1:50 (conjugated to Alexa 647; Invi-
trogen) and 49,6-diamidino-2-phenylindole (Sigma-life science) at
1:1000.
2.5. Tracing
Adult mice (.7weeks) were placed in a plastic chamber receiving
constant air flow of 430 mL/M and 3% to 4% isoflurane (Baxter,
San Juan, Puerto Rico). Once anesthetized, the mouse was
placed in a stereotaxic frame with a mask supplying air and
isoflurane. Eye drops (Oftagel; Santen, Solna, Sweden) were
applied to prevent dry eyes. Using a Q-tip, iodine (Jodopax;
Pharmaxim) was applied onto the head of the mouse followed by
a subcutaneous injection of 0.1 mL of the local anesthetic
lidocaine (10 mg/mL; Apoteket). After 3 minutes, a scalpel was
used tomake a cut across the head exposing the skull. Hydrogen
peroxide (30%) was applied onto the skull with a Q-tip, revealing
the bregma and lambda. Once the coordinates were located for
the lateral parabrachial nucleus (LPB) (AP:25.20, ML: 1.20, DV:
3.50) and ventral posterolateral/medial thalamic nucleus (VPL/
VPM) (AP: 21.94, ML: 1.70, DV: 3.75), a small hole was drilled
and 100 nL of the retrograde tracer fluorogold (FG) (4%,
FluoroChrome) was injected bilaterally. The needle was left at
the injection site for 8 minutes before removal. The incision was
sewed together using a suture (6 mm, Vicryl Rapide; Ethicon) and
double knot after every stitch. Themouse was later returned to its
home cage after receiving postoperative analgesic 0.03 mg/kg
buprenorphine (Vetergesic; Orion Pharma). Animals were sacri-
ficed 5 to 12 days postsurgery, and the tissue was handled
according to procedures explained under tissue preparation. The
brain was embedded in 4%agarose (Amresco, VWR, Stockholm,
Sweden) and cut 60 mm thick on a vibratome (Leica Micro-
systems, Stockholm, Sweden), whereas the spinal cord was
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embedded in O.C.T compound (Bio-Optica, Milano, Italy) and cut
16 to 30 mm thick for LPB and 30 to 60 mm for VPL/VPM.
2.6. Virus injection
Male and female Grpr-Cremice aged 4 to 6months were used for
the virus injection experiments. The mice were anesthetized
through inhalation of isoflurane (Baxter, induction at 4%,
continuous anesthesia at 2%), and the body temperature was
monitored and maintained at 36 to 37˚C under the procedure
using a heating pad (CMA). The fur on the back was shaved. The
skin was cleaned with iodine (Jodopax vet; Pharmaxim, 20 mL/L
in water) and a 1-cm incision was made along the midline above
vertebrae T12-13 followed by a second incision that went through
the connective tissue covering these 2 vertebrae. Next, cuts were
made into the muscle on each side of T13 vertebra and a clamp
was inserted to secure the spinal column. The ligamentum flavum
connecting T12 with T13 was cut to reveal the spinal cord. Two
injections of 500 nL virus each were made into the spinal cord
parenchyma 0.4 mm right of the midline and 0.5 to 1 mm apart
using a 10-mL Nanofil Hamilton syringe (WPI) with a 34G beveled
needle (WPI) guided by a microsyringe pump controller (WPI)
mounted on a stereotaxic frame. The tissue was kept moist
throughout the procedure by continuous application of sterile
saline (9 mg/mL; Fresenius Kabi) on the surgical area. AAV8/
hSyn-DIO-mCherry (lot number AV4981F, titer: 6.1 3 1012 vg/
mL) was purchased from UNC Vector core and AAV9/CAG-DIO-
GCaMP6f-WPRE (lot number CS0722, titer 15.2 3 1012 vg/mL)
from UPenn Vector core. Bupivacaine (Marcain; AstraZeneca, 2
mg/kg, subcutaneous) was administered as a local anesthetic at
the site of surgery and buprenorphine (Vetergesic Vet; Orion
Pharma, 0.1 mg/kg, subcutaneous) was used for postoperative
analgesia. The animals were left 2 to 10 weeks after surgery
before use in any experiments to achieve full recovery and
efficient virus expression.
2.7. Single-cell PCR
Individual neurons for single-cell analysis were isolated through
microdissection; here, adult (.7 weeks) tdTomato;Grpr-Cre–
positive animals were euthanized with a of 0.5 mg/mL ketamine
hydrochloride (Ketaminol; Pfizer) and 0.5 mg/mL medetomidine
hydrochloride (Domitor; Orion Pharma). The mice were perfused,
as described in section 2.3., with RNase free 13 phosphate-
buffered saline, and the spinal cord was removed and immediately
frozen oncrusheddry ice. The frozen spinal cordwasdry sectioned
10 mm thick and collected on membrane slides (Leica Micro-
systems). Single fluorescent tdTomato–positive cells from themost
dorsal (predominately laminae I-III) spinal cord were picked using
laser microdissection (Leica DM 600B) and collected in single
tubes (VWR) containing cell collection solution (water, 0.1 M DTT
[Invitrogen] and 20 URNAse inhibitor [Fermentas]). The tubes were
snap frozen on dry ice and stored in280˚C freezer until they were
used for reverse transcription described below.
The single cells were thawed on ice for reverse transcription
where 10 mM dNTPs and random primers were added directly to
the tubes and incubated at 94˚C for 5 minutes. The tubes were
taken out immediately and incubated on ice for 5 minutes before
13 first-strand buffer (Invitrogen), 20 U RNAse inhibitor, and
M-MLV (Invitrogen) were added followed by incubation at 37˚C for
1 hour. To deactivate the enzyme, the reaction was incubated at
70˚C for 15 minutes and was used in 2 rounds of PCR with 2
different primer pairs. In the first round of PCR, the following
solutions were used: 103 buffer (Invitrogen), 1.5 mM MgCl
(Invitrogen), 0.5 U Platinum Taq (Invitrogen), and 0.4 mM of the
primers. The same solutions were used in the second round
(nested) of PCR together with 5 mL product from the first round
of PCR, however with another primer pair. The protein b-actin
was used as a positive control to ensure that the single tubes
contained DNA. cDNA from the spinal cord and a water sample
was included in each PCR to ensure that the protocol was
optimal and that there were no contamination, respectively.
The following primers were used in the first round of PCR:
Grpr 59-catctctagcctggctttgg -39 (forward) and 59-agatcttcat-
cagggcatgg-39 (reverse); Vglut2 59-gccgctacatcatagccatc-39
(forward) and 59-gctctctccaatgctctcctc-39 (reverse); b-actin
59-ctcttttccagccttccttctt-39 (forward) and 59-agtaatctccttctg-
catcctgtc-39 (reverse). In the nested PCR, the following primers
were used: Grpr 59-cagcaagtacctggctgaca-39 (forward) and
59-ggggttagtgctcttgaagg-39 (reverse); Vglut2 59-acatggtcaacaa-
cagcactatc-39 (forward) and 59-ataagacaccagaagccagaaca-39
(reverse). To ensure that the designed Grpr primers were specific,
the Grpr product was sent for sequencing (Eurofins Genomics,
Ebersberg, Germany) after the nested PCR.
2.8. Imaging
The images were obtained using a Mirax microscope (Pannor-
amic MIDI, 3D HISTECH; Hitachi, Tokyo, Japan) or an Olympus
BX61WI microscope (Olympus, Lund, Sweden).
2.9. Electrophysiology and calcium imaging
Coronal 300 mm thick spinal cord slices from tdTomato;Grpr-Cre
neonates (P4-P12) were prepared in a cold (4˚C) sucrose-based
oxygenated (95% O2 and 5% CO2) cutting solution composed of
(mM): 2.49 KCl, 1.43 NaH2PO4, 26 NaHCO3, 10 glucose, 252
sucrose, 1 CaCl2, 4 MgCl2. Alternatively, virus-injected Grpr-Cre
adult mice (4-6 months old) were perfused and their spinal cord
dissected and sliced in cold NMDG-HEPES–based recovery
solution composed of (mM): 93N-methyl-D-glucamine, 2.50 KCl,
1.20 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 Glucose, 5 sodium
ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO4.7H2O, 0.5
CaCl2.2H2O. Thereafter, the slices were incubated at room
temperature for 1 hour in a bubbling (with 95% O2 and 5% CO2)
chamber containing normal artificial cerebrospinal fluid (mM): 126
NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose, 1.5
CaCl2, 1.5 MgCl2. The slices were then transferred to a recording
chamber whereby Grpr-Cre neurons were identified using a 603
water-immersion objective (LUMPlan FI, 0.90 numerical aperture;
Olympus) through either red fluorescent protein for patch clamp
or green fluorescent protein for calcium imaging, visualized on
a Zyla sCMOS camera (Andor Technology Ltd, Belfast, United
Kingdom) connected to a green (550 nm) or blue (490 nm;
CoolLED System, Andover, United Kingdom) fluorescent LED
light source. Patch electrodes (6-12 MV) from borosilicate
glass capillaries (GC150F-10 Harvard Apparatus) pulled on
a PC-10 gravitational pipette puller (Narishige, Tokyo, Japan)
contained a K1-based internal solution (in mM): 120 K-
gluconate, 40 HEPES, 1.02 MgCl2, 2.17 MgATP, 0.34 NaGTP,
with pH adjusted to 7.2 using 1 M KOH with an osmolarity of
266 mOsm/L. Liquid junction potential was corrected before
each patched neuron.
Whole-cell patch-clamp recordings were made using a multi-
clamp 700B amplifier (Molecular Devices, Sunnyvale, CA) and
digitalized with Digidata 1440A (Molecular Devices), low pass
filtered at 10 kHz, digitized at 20 kHz, and acquired and analyzed
in WinWCP software (Dr J. Dempster, University of Strathclyde,
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Glasgow, United Kingdom), and MATLAB (MathWorks, Natick,
MA). Grpr-Cre neurons were voltage clamped at 260 mV and
those with a stable restingmembrane potential (Vm) lower than2
45 mV were included in analysis. Grpr-Cre neuronal firing was
examined by current injections (0-50 pA, 1 second, 10 pA
increments) in current clamp with a 3-second step interval to
assure membrane potentials returned to baseline. Action
potentials (APs) elicited from depolarizing current pulses (5 pA
increments, 10 ms), from rest, were analyzed for AP threshold,
noted as the point when the increase in membrane potential
exceeds 20 mV/ms.
After established spike profile and AP threshold, a 20-minute
free-run protocol was recorded for each cell and 300 nM of GRP
(Phoenix Europe GmbH, Burlingame, CA) was added. The
agonist reached the bath in the recording chamber two and
a half minutes of baseline and washed in for a total of 5 minutes.
Subthreshold depolarization and induced spike activity were then
analyzed.
Calcium-imaging responses from Grpr-Cre AAV9/CAG-DIO-
GCaMP6–infected neurons to bath-applied NPPB (40 nM;
Phoenix Europe GmbH) were recorded through a blue LED
excitation light, and signals were acquired in a frame rate of 2 Hz.
Each experiment consisted of 1.5minutes of baseline followed by
NPPB perfusion for a total of 5-minute recordings. Data
presented here show relative change in the fluorescence signal
from a region of interest. ΔF/Fwas calculated based on the mean
value from the first 50 seconds of baseline.
2.10. Behavior
All behavior analyses were performed in a controlled environment
at 20 to 24˚C, 45% to 65%humidity, and 12-hour day/night cycle.
The observers were blind to the genotype.
2.10.1. Spontaneous itch
The mice were placed in a transparent cage with bedding and
recorded with a digital camera for 30 minutes. The scratching
episodes were scored using the software AniTracker v1.0, and
the results were displayed as the mean number of scratching
episodes per group in 30 minutes.
2.10.2. Chemically induced itch
Adult (.7 weeks) Vglut2-loxf/f;Grpr-Cretg/wt (conditional knock-
outs) and Vglut2-loxf/f;Grpr-Crewt/wt (controls) littermates were
injected intradermally in the nape of the neck with 50 mL saline
(9 mg/mL; Apoteket), placed in a transparent cage with bedding,
and recorded for 1 hour. The subsequent day, the same animals
were injected with 50 mL of compound 48/80 (10 mg; Sigma) or
chloroquine (10 mM; Sigma) and recorded for another hour. The
amount of scratching episodes was scored using the software
AniTracker v1.0, and the data were presented as the mean
number of scratching episodes for each group in 1 hour.
2.11. Pain
2.11.1. Von Frey
The mice were placed in transparent plastic chambers that were
placed on an elevated metallic mesh floor for 90 minutes before
the initiation of the experiment (acclimatization). Von Frey
filaments (Scientific Marketing Associates) were applied on the
planar surface of the hind paw of each mouse according to the
Chaplain up–down paradigm.5 A lift of the treated paw was
considered a reaction to the applied filament and a thinner
filament was applied subsequently, while a lack of reaction
resulted in application of a thicker filament. Every observation
started with 0.6 g filament and the experiment was ended once 6
measurements were obtained around the 50% threshold. The
Dixon method8 was used to calculate the 50% threshold.
2.11.2. Randall–Selitto
The mice were restrained in a transparent cylinder with their tail
hanging out and left to acclimatize for 15 to 20 minutes. The
Randall–Selitto arm22 was placed on the tail and increasing
pressure was applied until a reaction (tail flick) was observed and
the machine was stopped. The test was repeated at least 3 times
with 10 to 15 minutes between each test. The cutoff weight was
500 g, and the results were expressed as mean withdrawal
latency in grams for each animal.
2.11.3. Hargreaves
The mice were placed in transparent plastic chambers that were
placed on top of a glass floor for 90 minutes until no exploratory
behavior was observed. A thermal laser beam (IITC Life Science,
Woodland Hills, CA) was directed towards their planar hind paws
and the time until paw withdrawal was noted. The test had
a cutoff time of 20 seconds andwas repeated at least 3 timeswith
5 minutes between each observation. The result was presented
as the mean withdrawal latency (s) for each animal and group.
2.11.4. Tail withdrawal test
The mice were restrained in a plastic cylinder and left to
acclimatize for 15 to 20 minutes before the tail was dipped
halfway into215˚C ethanol. The tail was removed when a tail flick
was observed or the cutoff time of 30 seconds was reached. The
test was repeated at least 3 times with 5 to 10 minutes between
each test, and the results were displayed as the mean withdrawal
latency (s) for each animal and group.
2.12. Statistics
Nonparametric calculations of P values between 2 groups were
conducted using the Mann–Whitney 2-tailed test. Neuronal
membrane potential, input resistance, and AP threshold are
presented asmean andSE. The computer programPrism version
5.01 (GraphPad Software Inc, La Jolla, CA) was used for all
statistical tests.
3. Results
3.1. Grpr-Cre–expressing neurons comprise the
Grpr population
To investigate the role of spinal GRPR-expressing neurons in itch
transmission, we constructed a Grpr-Cre line using BAC cloning
(Fig. 1). The Cre sequence together with an ampicillin cassette
surrounded by frt sites was inserted into the vector replacing exon 1
of the Grpr gene (Fig. 1A). Digestion with restriction enzymes and
pulsed-field electrophoresis revealed successful electroporation
with 2 bands sized 180 and 8.7 kb for thewild type allele, whereas 3
bands sized 112, 70, and 8.7 kb were obtained for themutant allele
(Fig. 1B). Twohealthy and viableGrpr-Cre foundersweregenerated
through pronuclear injection. To visualize the expression of Grpr-
Cre, the linewas crossedwithROSA26-loxP-STOP-loxP-tdTomato
mice (hereafter referred to as tdTomato), which labels all Cre-active
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cells fluorescently red.27 Single-cell analysis of tdTomato;Grpr-Cre
cells gave a Grpr-specific band of 152 bp in 32% of Grpr-Cre cells
(n 5 86) (Fig. 1C), whereas none of the nonfluorescent cells
expressed GrprmRNA (n5 46), which indicates that the Grpr-Cre
line includes the actual GrprmRNA–expressing population.
To further evaluate GRPR expression in Grpr-Cre mice, the
neuropeptideGRP (300nM)wasbath applied to patched tdTomato;
Grpr-Cre cells located in the superficial layers of the dorsal horn
spinal cord (Fig. 1D–I). Here, 43.3% (13/30) of the patched cells
responded with APs of 0.5 6 0.2 Hz during GRP application
(Fig. 1E). Of those, 9 (69.2%) exhibited tonic (Fig. 1F), 2 (15.4%)
adapting, and the other 2 (15.4%) delayed spike profile. The mean
resting membrane potential was256.86 1.7 mV, input resistance
387.36 30.9MV, and AP threshold230.66 1.2mV. In addition to
the GRP spike-induced cells (43.3%), 16.7% (5/30) of the patched
neurons respondedwith subthreshold depolarization ranging from7
to 9 mV (Fig. 1H). Of these, 3 cells (60.0%) exhibited an adapting
profile, whereas the remaining 2 (40.0%) displayed a gap firing spike
profile (Fig. 1I). Their resting membrane potential had a mean value
of257.1061.46mV, the input resistance407.00647.08MV, and
AP threshold 231.4 6 1.6 mV (for a complementary electrophys-
iological analysis of the Grpr-Cre population, see Supplemental
Fig. 1, available online at http://links.lww.com/PAIN/A389).
Also, patch-clamp analysis of AAV8/hSyn-DIO-mCherry–infected
Grpr-Cre neurons showed that out of 9 patched cells from 4
different animals (with mean values for resting membrane potential
and input resistanceof258.2961.56mVand338.1668.46MV,
respectively), 2 responded with induced spikes (Supplemental
Fig. 2, available online at http://links.lww.com/PAIN/A389), 5 with
subthreshold depolarization of 5.006 0.45 mV, and the remaining
2 with hyperpolarization of212.006 1.00 mV. Furthermore, input
resistance decreased to 283.96 6 6.16 MV after GRP bath
application. These data further confirm that the Grpr-Cre
population comprises GRPR/Grpr-expressing cells.
Figure 1.Construction of Grpr-Cre using BAC cloning. (A) Schematic overview of the generation of Grpr-Cre mice. The Cre sequence together with an ampicillin-
resistance cassette flanked by 2 frt sequences was inserted through homologous recombination to replace exon 1 in theGrpr locus. Once inserted, the ampicillin-
resistance gene was removed by the addition of arabinose, leaving only the Cre sequence under the influence of the Grpr promoter. (B) A pulsed-field gel
electrophoresis image showing BAC-wt (180 bp and 8734 bp), BAC-Cre (112 kb, 70 kb, and 8734 bp), and arabinose-treated Cre (181 kb and 8734 bp). (C)
Electrophoresis gel image from the single-cell analysis showing a positive and a negative cell forGrpr, ladder 100 bp. iCre (codon-improved Cre), frt (frt site), Amp
(ampicillin-resistance gene). (D, E) Induction of action potentials in a tdTomato;Grpr-Cre cell when 300 nM gastrin-releasing peptide (GRP) was applied to the
recording chamber. (F) Tonic spike profile exhibited by the recorded tdTomato;Grpr-Cre cell (D) when 30 pA current was applied. (G, H) A subthreshold
depolarization response from a tdTomato;Grpr-Cre cell when 300 nM GRP was applied to the bath in the recording chamber. (I) A gap firing spike profile was
exhibited by the recorded tdTomato;Grpr-Cre cell (G) when 30 pA of current was applied. Scale bars, 30 mm.
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3.2. Grpr-Cre neurons in the spinal cord aremainly excitatory
To determine the expression of Grpr-Cre in the central and
peripheral nervous system and the gross transmitter phenotype,
tdTomato;Grpr-Cre mice were subsequently crossed with the
Viaat (vesicular inhibitory amino acid transporter)-egfp line to
visualize inhibitory neurons. The density of Grpr-Cre–expressing
cells and the overlap with Viaat-egfp expression was graded as
sporadic (1), intermediate (11), or dense (111) for each
evaluated brain structure, spinal cord segment, or peripheral
structure analyzed.Grpr-Cre expressionwas identified in a number
Figure 2. Expression of Grpr-Cre and Viaat-egfp in the brain. (A-P) Coronal section of a postnatal (P4) brain showingGrpr-Cre–expressing cells by the reporter line
tdTomato indicated by red fluorescence (B, F, J, N) and Viaat-egfp–expressing neurons seen in green via the reporter Viaat-egfp (C, G, K, O). (A) Grpr-Cre activity
was seen in certain brain regions, including the caudate putamen. (B-D) Enlargement of the caudate putamen. (E) Grpr-Cre activity was seen in the cortex. (F-H)
Enlargement of the primary and secondary somatosensory cortices. (I) Grpr-Cre activity was seen in the central medial thalamic nuclei and paracentral thalamic
nucleus. (J-L) Enlargement of the central medial thalamic nuclei and paracentral thalamic nucleus. (M) Grpr-Cre activity was seen in the spinal trigeminal nucleus.
(N-P) Enlargement of the spinal trigeminal nucleus. Scale bars: 100mm (A, E, I); 200mm (B,M, N), and 500mm (F, J). An antibody against green fluorescent protein
was used to enhance detection. The arrows highlight examples of coexpression of green fluorescent protein andGrpr-Cre. CM, central medial thalamic nuclei; CL,
centrolateral thalamic nuclei; CPu, caudate putamen; GP, globus pallidus; MD, mediodorsal thalamic nuclei; S1HL, primary somatosensory cortex, hindlimb
region; S1Sh, primary somatosensory cortex, shoulder region; S1BF, primary somatosensory cortex, barrel field; S1ULp, primary somatosensory cortex, upper lip
region; S2, secondary somatosensory cortex; Sp5, spinal trigeminal nucleus; PC, paracentral thalamic nucleus; PV, paraventricular thalamic nuclei; VPL, ventral
posterolateral thalamic nuclei.
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Table 1
tdTomato;Grpr-Cre and Viaat-egfp expression in P4 mouse brain.
Structure Structure (full name) Grpr-Cre Viaat-egfp Vglut2 in situ*
5N Motor trigeminal nucleus 1 1
10N Dorsal motor nucleus of vagus 1
AA Anterior amygdaloid area 11 1
Acbc Accumbens nucleus, core 111
AcbSh Accumbens nucleus, shell 111
ACo Anterior cortical amygdaloid area 1 1
AHA Anterodorsal thalamic nucleus 1
AHiAL Amygdalohip area, antolateral 1
AHiPM Amygdalohippocampal area, posteromedial part 1 1
AHP Anterior hypothalamic area, posterior part 1
AID Agranular insular cortex, dorsal part 1
AIP Agranular insular cortex, posterior part 1
AIV Agranular insular cortex, ventral part 1 1
AOD Anterior olfactory area, dorsal part 1 1
AOL Anterior olfactory area, lateral part 1 1
AOM Anterior olfactory area medial part 1
AOP Anterior olfactory area posterior part 1
AOV Anterior olfactory area ventral part 1 1
AP Area postrema 111
APT Anterior pretectal nucleus 1 111
Arc Arcuate hypothalamic nucleus 11
ArcD Arcuate hypothalamic nucleus, dorsal part 111
ArcL Arcuate hypothalamic nucleus, lateral part 111
ArcM Arcuate hypothalamic nucleus, medial part 111
ATg Anterior tegmental nucleus 1 11
Au1 Primary auditory cortex 1
AuD Secondary auditory cortex, dorsal 1 1
AVPe Anteroventral periventricular nucleus 1 1
AuV Secondary auditory cortex, ventral area 1
BMA Basomedial amygdaloid nucleus, anterior part 11 1 111
CA1 Field CA1 of the hippocampus 1 1 11
CA2 Field CA2 of the hippocampus 1 1 11
CA3 Field CA3 of the hippocampus 1 1 11
CeC Central amygdaloid nucleus, capsular 11
CeM Central amygdaloid nucleus, medial division 11
CEnt Caudomedial entorhinal cortex 1
Cerebellum 111 1
Cg 1 Cingulate cortex, area 1 1 1
Cg2 Cingulate cortex, area 2 1 1
CI Claustrum 1
CIC Central nucleus of the inferior colliculus 11 111
CL Centrolateral thalamic nucleus 1
CM Central medial thalamic nucleus 11 111
CP Cerebral peduncle 111 projections
CPu Caudate putamen (striatum) 111 1 projections
(continued on next page)
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Table 1 (continued)
Structure Structure (full name) Grpr-Cre Viaat-egfp Vglut2 in situ*
CxA Cortex-amygdala transition zone 1 1 1
DC Dorsal cochlear nucleus 11
DCIC Dorsal cortex of the inferior colliculus 11 1 111
DEn Dorsal endopiriform claustrum 1
DEN Dorsal endopiriform nucleus 1
DG Dentate gyrus 11 1
DI Dysgranular insular cortex 1 1 1
DIEnt Dorsal intermediate entorhinal cortex 1
DLEnt Dorsolateral entorhinal cortex 1 1
DLO Dorsolateral orbital cortex 1 1
DLPAG Dorsolateral periaqueductal gray 1 1 111
DM Dorsomedial hypothalamic nucleus 111 1
DMC Dorsomedial hypothalamic nucleus, compact part 111
DMPAG Dorsomedial periaqueductal gray 1 111
DMSp5 Dorsomedial spinal trigeminal nucleus 11
DMTg Dorsomedial tegmental area 1 1
DP Dorsal peduncular cortex 1 1
DRD Dorsal raphe nucleus, dorsal part 1
DRL Dorsal raphe nucleus, lateral part 1
DRV Dorsal raphe nucleus, ventral part 1
DS Dorsal subiculum 1 1 11
EAC Extended amygdala, central part 1
EAM Extended amygdala, medial part 11
ECIC External cortex of the inferior colliculus 1 1 111
Ect Ectorhinal cortex 1 1
EP Entopeduncular cortex 1 projections 1 projections 1
Fr3 Frontal cortex, area 3 1
FrA Frontal association cortex 11 11
Fu Bed nucleus of the stria terminalis, fusiform part 1
Gi Gigantocellular reticular nucleus 1 1
GI Granular insular cortex 1 1
GP Globus pallidus 111 projections 1 projections
GrO Granule cell layer of the olfactory bulb 1 1
HDB Nucleus of the horizontal limb of the diagonal band 1 11
IEn Intermediate endopiriform claustrum 1
IG Indusium griseum 11
IL Infralimbic cortex 1 1 Projections
InG Intermediate gray layer SC 11 111
InWh Intermediate white layer SC 1 111
IOM Inferior olive, medial nucleus 1 1
IPACL Interstitial nucleus of the posterior limb in the
anterior commissure, lateral part
11
IPACM Interstitial nucleus of the posterior limb in the
anterior commissure, medial part
11
IPDM Interpeduncular nucleus, dorsomedial subnucleus 111
IRt Intermediate reticular nucleus 1
(continued on next page)
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Table 1 (continued)
Structure Structure (full name) Grpr-Cre Viaat-egfp Vglut2 in situ*
KF Kolliker-Fuse nucleus 1 11
LA Lateroanterior hypothalamic nucleus 1 111
LAcbSh Lateral accumbens shell 1
LH Lateral hypothalamic area 11 1 1
LHb Lateral habenular nucleus, lateral 11
LO Lateral orbital cortex 11 1
LPAG Lateral periaqueductal gray 1 111
LPBC Lateral parabrachial nucleus, central part 11 11
LPGi Lateral paragigantocellular nucleus 1
LPMR Lateral posterior thalamic nucleus, mediorostral 1 11
LPtA Lateral parietal association cortex 1
LSI Lateral septal nucleus, intermediate part 11 1
M1 Primary motor cortex 1 1
M2 Secondary motor cortex 1 1
mcp Middle cerebellar peduncle 1 1
MD Mediodorsal thalamic nucleus 111 111
MdD Medullary reticular nucleus, dorsal part 11
MdV Medullary reticular nucleus, ventral part 1 1
ME Median eminence 11
MeA Medial amygdaloid nucleus, anterior part 11
MeAV Medial amygdaloid nucleus, anteroventral part 11 111
MEnt Medial entorhinal cortex 1 1
MePD Medial amygdaloid nucleus, posterodorsal 1
MePV Medial amygdaloid nucleus, posteroventral 11 111
mfb Medial forebrain bundle 11 1 projections 1
MiTg Microcellular tegmental nucleus 1 1
ml Medial lemniscus 111
ML Mammillary nucleus, medial part 1 111
MO Medial orbital cortex 1 1
MoDG Molecular layer of the dentate gyrus 11 1
MPA Medial preoptic area 1 1 1
MPOL Medial preoptic nucleus, lateral part 1
MPOM Medial preoptic nucleus, medial part 1 1
MPtA Medial parietal association cortex 1
MVePC Medial vestibular nucleus, magnocellular part 1 1
Op Optic nerve layer of the superior colliculus 1 11
OT Nucleus of the optic tract 11 1
P1Rt p1 periaqueductal gray 1
PaAP Paraventricular hypothalamic nucleus, anterior
parvocellular part
11 1
PaMP Paraventricular hypothalamic nucleus, medial
parvocellular part
111
PaLM Paraventricular hypothalamic nucleus, lateral
magnocellular part
111
PaPo Paraventricular hypothalamic nucleus, posterior
part
11 11
PaS Parasubiculum 1 1
(continued on next page)
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Table 1 (continued)
Structure Structure (full name) Grpr-Cre Viaat-egfp Vglut2 in situ*
PC Paracentral thalamic nucleus 1 111
PCRtA Parvocellular reticular nucleus, alpha part 1 1
PDR Posterodorsal raphe nucleus 1
Pe Periventricular hypothalamic nucleus 1
PH Posterior hypothalamic nucleus 1 11
PHD Posterior hypothalamic nucleus, dorsal part 1
Pir Piriform cortex 1 1 1
PL Paralemniscal nucleus 1 1 projections 11
PLCo Posterolateral cortical amygdala 111 1
PLH Peduncular part of lateral hypothalamus 111 projections 11
PMCo Posteromedial cortical amygdaloid area 1 111
Pn Pontine nuclei 1 11
PnC Pontine reticular nucleus, caudal part 1 1 1
PnO Pontine reticular nucleus, oral part 1 1 11
PoDG Polymorph layer of the dentate gyrus 11 1
Post Postsubiculum 1 1
Pr5 Principal sensory trigeminal nucleus 1 projections 11
Pr5VL Principal sensory trigeminal nucleus, ventrolateral
part
1 1 1
PrCnF Precuneiform area 11 1 1
PRh Perirhinal cortex 1
PrL Prelimbic cortex 1 1 Projections
PrS Presubiculum 1 1
Ps Parastrial nucleus 1
PSTh Parasubthalamic nucleus 11 111
PV Paraventricular thalamic nucleus 111 111
RAPir Rostal amygdalopiriform 11
RChL Retrochiasmatic area 11
RML Retromammillary nucleus 11 111
RSA Retrosplenial agranular cortex 11
RSD Retrosplenial dysgranular cortex 1 1
RSGa Retrosplenial granular cortex, a region 1 1
RSGb Retrosplenial granular cortex, b region 1 1
RSGc Retrosplenial granular cortex, c region 1 1
Rt Reticular nucleus (prethalamus) 111
RTg Reticulotegmental nucleus of the pons 11
S1 Primary somatosensory cortex 1
S1BF Primary somatosensory cortex, barrel region 11 1
S1DZ Primary somatosensory cortex, forelimb region 1 1
S1FL Primary somatosensory cortex, forelimb region 1 1
S1HL Primary somatosensory cortex, hindlimb region 1 1
S1J Primary somatosensory cortex, jaw region 1 1
S1Sh Primary somatosensory cortex, shoulder region 1 1
S1Tr Primary somatosensory cortex, trunk region 1 1
S1ULp Primary somatosensory cortex, upper lip region 1 1
S2 Secondary somatosensory cortex 1 1
(continued on next page)
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Table 1 (continued)
Structure Structure (full name) Grpr-Cre Viaat-egfp Vglut2 in situ*
SFi Septofimbrial nucleus 1
Shy Septohypothalamic nucleus 1 11
SNR Substantia nigra 111 projections 111 projections
SolDL Solitary nucleus, dorsolateral part 11
SolDM Solitary nucleus, dorsomedial part 11
SolM Solitary nucleus, medial part 11
SolVL Solitary nucleus, ventrolateral part 11
Sp5 Spinal trigeminal tract 11 projections 1
Sp5C Spinal trigeminal nucleus, caudal part 111 1
Sp5I Spinal trigeminal nucleus, interpolar part 111 1
SpVe Spinal vestibular nucleus 11 1
St Stria terminalis 11
ST Bed nucleus of the stria terminalis 11
STLD Bed nucleus of the stria terminalis, lateral division,
dorsal part
11
STLJ Bed nucleus of the stria terminalis, lateral division,
juxtacapsular part
11
STLP Bed nucleus of the stria terminalis, lateral division,
posterior part
111
STLV Bed nucleus of the stria terminalis, lateral division,
ventral part
1 1
STMA Bed nucleus of the stria terminalis, medial division,
anterior part
11
STMAL Bed nucleus of the stria terminalis, medial division,
anterolateral part
111
STML Bed nucleus of the stria terminalis, medial division,
posterolateral part
11
STr Subiculum, transition area 1
SuG Superficial gray layer of the superior colliculus 1 1 11
SubCD Subcoeruleus nucleus, dorsal part 1 1
SubB Subbrachial nucleus 1 1
SuVe Superior vestibular nucleus 1
TeA Temporal association cortex 1 1
tfp Transverse fibers of pons 111
Tu Olfactory tubercle 111 1
TuLH Tuberal region of lateral hypothalamus 1 1
V1 Primary visual cortex 1 1
V1B Primary visual cortex, binocular area 1 1
V1M Primary visual cortex, monocular area 1 1
V2L Secondary visual cortex, lateral area 1 1
V2ML Secondary visual cortex, mediolateral 1 1
V2MM Secondary visual cortex, mediomedial 1 1
VCA Ventral cochlear nucleus, anterior part 11 1 11
VCP Ventral cochlear nucleus, posterior part 11
VEN Ventral endopiriform nucleus 1 1
VIEnt Ventral intermediate entorhinal cortex 1 1
VLL Projections
VMHC Ventromedial hypothalamic nucleus, central 11 11
(continued on next page)
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of nuclei throughout the brain (Fig. 2, Table 1). Particularly, dense
Grpr-Cre expression was found in the caudate putamen
(Fig. 2A–D) and globus pallidus (Table 1, Fig. 2E–H), where
a majority of the cells in the caudate putamen overlapped with
Viaat-egfp (Fig. 2B–D). Intermediate-to-sporadic Grpr-Cre ex-
pression was seen in both primary and secondary somatosensory
cortices, predominantly in layer 2 and sporadically in layers 1 and 3
(Fig. 2E–H). A few of these cells overlappedwith Viaat-egfp, which
was expressed throughout the primary and secondary somato-
sensory cortices with the highest expression in layers 3 and 4 (Fig.
2F–H). Dense expression was seen in several thalamic structures,
including paraventricular thalamic nuclei, mediodorsal thalamic
nuclei, and central medial thalamic nuclei, whereas the expression
was sporadic in paracentral thalamic nucleus and centrolateral
thalamic nucleus (Fig. 2E, I–L). None of the Grpr-Cre–expressing
nuclei in the thalamic region overlapwithViaat-egfp, which indicate
that most Grpr-Cre–expressing nuclei in the thalamus are
excitatory (Fig. 2E, I–L). This was further supported by a compar-
ative Vglut2 analysis, where dense expression of the transporter
was visible in the above-mentioned thalamic structures (Table 1).34
Grpr-Cre expression was also dense in the spinal trigeminal
nucleus, which overlapped sporadic with Viaat-egfp (Fig. 2M–P).
Besides the thalamus, several other itch-processing nuclei19
showed the expression of Grpr-Cre, including the periaqueductal
gray and parabrachial nucleus. Here, sporadic expression of Grpr-
Crewas evident in the dorsolateral, lateral periaqueductal gray and
ventrolateral periaqueductal gray (Table 1), whereas the expres-
sion was intermediate in the LPB (Table 1).
In the spinal cord, an intermediate number of Grpr-Cre–positive
cells were found within laminae II, III, and IV, whereas sporadic
expression could be detected in lamina I and deeper lamina (Fig.
3A–C). Inner lamina II was detected using the marker IB4. To
determine whether Grpr-Cre cells were neurons or glial cells,
overlap with the pan-neuronal marker NeuN was analyzed. Our
analysis revealed that 97% of Grpr-Cre cells coexpressed NeuN
(298 of 307) (Fig. 3D–F), indicating that Grpr-Cre cells are neurons.
Concurrently, in laminae I-VI, only 11% of the Grpr-Cre–active
neurons showed immunoreactivity towards Viaat-egfp (18 of 162)
(Fig. 3G–I) and 6%with Pax2, a transcription factor that is required
for the expression of GABAergic neurons during development6 (10
of 183) (Fig. 3J–L). These results imply thatGrpr-Cre neurons in the
spinal cord are predominately excitatory. Expression of Grpr-Cre in
the DRG was also analyzed to assess whether the population was
restricted to the central nervous system or if Grpr-Cre was also
active in the periphery. On average, only 4 Grpr-Cre neurons were
located/DRG section (28 sections) (Supplemental Fig. 3, available
online at http://links.lww.com/PAIN/A389). Thus, Grpr-Cre activity
is mainly confined to neurons within the central nervous system.
3.3. Spinal Grpr-Cre neurons represent
predominately interneurons
To determine the termination of spinal cord Grpr-Cre neuron
projections, tracing analyses were performed. The retrograde
tracer FG was injected in LPB, VPL, and VPM of adult mice, and
subsequently, traced projection neurons in the lumbar spinal cord
were imaged (Fig. 4). Lateral parabrachial nucleus injections
resulted in 137 FG-positive spinal cord cells, located in lamina I/
lateral spinal nuclei (n5 96), lamina V/VII/VIII (n5 38), and lamina
X (n 5 3) (Fig. 4A–I), whereas injections targeting VPL/VPM
resulted in 66 FG-positive cells located in laminae V (n5 25) and
VI (n 5 41) (Fig. 4J–R). None of the VPL/VPM-traced neurons
overlapped with Grpr-Cre (Fig. 4K–R) and only 2 (lateral spinal
nuclei, n 5 2) of the LPB-traced neurons overlapped with Grpr-
Cre (data not shown), which indicates that spinal Grpr-Cre
neurons do not extend projections outside the spinal cord and,
hence, are interneurons.
3.4. Grpr-Cre neurons use VGLUT2-mediated transmission
to convey itch
Overlap analysis between tdTomato;Grpr-Cre and Viaat-egfp
neurons in the spinal cord concluded that most Grpr-Cre neurons
are excitatory (Fig. 3G–I). To challenge this hypothesis, we
performed single-cell analysis of Grpr-Cre neurons, isolated through
lasermicrodissection, in the dorsal spinal cord. The analysis showed
that 51% of the analyzed Grpr-Cre population expressed Vglut2
(vesicular glutamate transporter 2) mRNA (n5 99), whereas 63% of
the Grpr mRNA–containing Grpr-Cre neurons expressed Vglut2
mRNA (n 5 24) (Fig. 5A); thus, corroborating our finding that Grpr
mRNA–expressing Grpr-Cre neurons are mainly excitatory.
To investigate the role of VGLUT2-mediated transmission inGrpr-
Cre neurons, we subsequently crossed the Grpr-Cre line with
Vglut2f/fmice. The resultingVglut2f/f;Grpr-Cre offspringwere healthy
and viable, but had a decreased bodyweight (17.760.74 g vs 21.1
6 0.91 g for littermate controls, P 5 1.4 3 1026). In sensory
behavioral analysis, the Vglut2f/f;Grpr-Cremice responded normally
to touch (Fig. 5B) and noxious thermal (Fig. 5C–D) stimuli, but
showed an elevated response to noxious mechanical stimuli
compared with littermate controls (119 6 10.0 g vs 75 6 8.2 g)
(Fig. 5E). The insertion of Cre did not affect the sensory behavioral
phenotype (Fig. 5B–F).
Table 1 (continued)
Structure Structure (full name) Grpr-Cre Viaat-egfp Vglut2 in situ*
VMHDM Ventromedial hypothalamic nucleus, dorsomedial
part
11 111
VMH Ventromedial hypothalamic nucleus 1 11
VMHVL Ventromedial hypothalamic nucleus, ventrolateral
part
11 111
VLPAG Ventrolateral periaqueductal gray 1 1 111
VLPO Ventrolateral preoptic nucleus 1
VP Ventral pallidum 111 projections 11
VTT Ventral tenia tecta 1 1
Grpr-Cre expression and overlap with the vesicular inhibitory amino acid transporter (Viaat) visualized using a transgenic line (forth panel), and with vesicular glutamate transporter 2 (Vglut2) mRNA (fifth panel)34 in different
brain nuclei. The expression and overlap was ranked either 1 sporadic, 11 intermediate, or 111 dense.
* Mackenzie et al., 2009, J Neurosci.
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Interestingly, the spontaneous itch behavior ofVglut2f/f;Grpr-Cre
mice was attenuated compared with littermate controls (7 6 3
scratch episodes per 30 minutes vs 14 6 2 scratch episodes per
30 minutes) (Fig. 5F). A mild intradermal provocation, induced by
an NaCl injection, resulted in an attenuated behavioral response in
Vglut2f/f;Grpr-Cre mice compared with littermate controls (20 6 6
scratch episodes per hour vs 41 6 8 scratch episodes per hour)
(Fig. 5G). These results indicate that theGrpr-Cre population relays
both spontaneous itch and the sensation of an isotonic injection via
VGLUT2-mediated transmission.We also set out to investigate the
role of VGLUT2-mediated transmission from Grpr-Cre neurons in
chemically induced itch by introducing the pruritic agents
compound 48/80 or chloroquine intradermally (Fig. 5G). The
Vglut2f/f;Grpr-Cre animals displayed reduced scratching behavior
for both the histaminergic substance compound 48/80 (40 6 8
scratch episodes per hour vs 2226 50 scratch episodes per hour)
(Fig. 5G) and the nonhistaminergic substance chloroquine (1436
44 scratch episodes per hour vs 5436 110 scratch episodes per
hour) (Fig. 5G), compared with control littermates. These
behavioral results further supported the excitatory nature of the
Grpr-Cre population and showed that Grpr-Cre interneurons
convey both spontaneous and chemically induced itch via
VGLUT2-mediated signaling.
To analyze the position and connectivity of the Grpr-Cre–
expressing neurons in relation to known itch-related dorsal horn
neuronal populations, the itch-associated neurotransmitter
NPPB17 was bath applied to spinal cord slices from Grpr-Cre
neurons infected with AAV9/CAG-DIO-GCaMP6. From the 52
analyzed gfp-expressing cells, 12 (23.1%) responded with a mean
61.4% 6 13.9% increase in their fluorescence intensity level
Figure 3. Grpr-Cre–expressing neurons in the spinal cord are primarily excitatory. Immunohistological analysis of transverse sections of tdTomato;Grpr-Cre
mouse spinal cord. (A-C) Adult lumbar spinal cord stained for IB4 (green), which marks inner lamina II. (D-F) Labeling of adult lumbar spinal cord with NeuN (green)
revealed that most (97%) Grpr-Cre–positive cells are NeuN positive. (G-I) Postnatal (P4) spinal cord showing Grpr-Cre (G) and Viaat-egfp (H) expression in the
spinal cord dorsal horn. (J-L) Adult dorsal spinal cord labeled for Grpr-Cre and Pax2 (green). Scale bars, 100 mm. The arrowheads highlight examples of
coexpression.
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(Fig. 5H and I) (n 5 2, 7 responding cells in the first animal and 5
responding cells in the second), suggesting a possible connectivity
between natriuretic peptide receptor A (NPRA) andGRPRneurons.
4. Discussion
Here, we constructed a Cre line, driven by the Grpr promoter,
to analyze Grpr-expressing neurons. Our single-cell and
electrophysiological analyses confirmed that we target Grpr-
expressing neurons, and our immunohistochemical and
tracing analysis revealed that Grpr-Cre is predominantly
expressed in excitatory interneurons in the dorsal horn of the
spinal cord, particularly in laminae II, III, and IV. Grpr-Cre is
almost absent in the DRG, whereas many structures in the
brain, including the striatum, showed dense expression. The
majority of Grpr-Cre–positive neurons in the brain overlapped
with Viaat. Moreover, the behavioral analysis of Vglut2f/f;
Grpr-Cre mice revealed that the Grpr-Cre population of
interneurons is central for conveying itch and signals via
VGLUT2-mediated transmission, as removal of Vglut2 re-
duced both spontaneous and induced scratching behavior
compared with littermate controls.
4.1. Grpr-Cre targets the Grpr population
Construction of a Cre line by BAC cloning uses random
integration for insertion. To confirm the accuracy of our Cre
insertion, we used several techniques where our single-cell
analysis showed that 32% of the tdTomato;Grpr-Cre population
expressedGrprmRNAand that allGrpr-expressing neuronswere
confined within the Grpr-Cre population. Moreover, our analysis
revealed that 43.3% of tdTomato;Grpr-Cre cells responded to
GRP application with induced APs, whichmatched our single-cell
analysis of Grpr mRNA–expressing Grpr-Cre neurons. Addition-
ally, 17% of the remaining patched cells responded with
subthreshold depolarization, consistent with previous reports.37
Interestingly, a high proportion (69%) of the spike responding cells
were here classified as tonic neurons, a class that mainly includes
excitatory interneurons.25 Reporter lines often display a larger Cre
population than actually present at the adult stage, due to
transient expression during the development.14,18 This is also
evident from our analysis of tdTomato;Grpr-Cre neurons. To
further analyze the active Grpr-Cre population at the adult stage,
AAV8/hSyn-DIO-mCherry virus was injected in adult Grpr-Cre
spinal cord tissue and all patched mCherry-positive neurons
responded to GRP. Thus, we can conclude that Grpr mRNA–
expressing neurons express Grpr-Cre and that Grpr-Cre neurons
respond to the peptide GRP. Consequently, Grpr-Cre can be
considered to target GRPR neurons.
4.2. Grpr-Cre neurons in the spinal cord dorsal horn
are interneurons
The analysis of spinal GRPR neurons has so far been based on in
situ hybridization,30 a Grpr-egfp line37 and real-time PCR,10
which concluded that Grpr is expressed in the most superficial
layers of the spinal cord, whilst being absent in the DRG.10,17,30
This is consistent with our finding that Grpr-Cre–expressing cells
Figure 4.Grpr-Cre neurons are predominately interneurons. Images of the spinal cord after injection of tracer FG (blue) at LPB (A-I) and VPL/VPM (J-R). (A) Injection
site of FG in LBP. Bregma24.96mm. (B-E) Examples of several projection neurons (blue, schematic in B) in lamina I where none of the traced neurons overlapwith
Grpr-Cre activity (red). (F-I) A representative traced neuron located in lamina V that did not overlap with Grpr-Cre activity. (J) Injection site of FG in VPL/VPM.
Bregma21.58 mm. K-R show several FG-positive neurons in laminae V and VI with no overlap with Grpr-Cre. Scale bar (A, J) 100 mm. Scale bar (C-E, G-I, L-N,
P-R) 37 mm. FG, fluorogold; LPB, lateral parabrachial nucleus; VPL, ventral posterolateral nucleus of thalamus; VPM, ventral posteromedial nucleus of thalamus.
The arrows denote the position of traced FG-positive neurons (projection neurons).
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are located in the dorsal spinal cord; however, we also observe
a few Grpr-Cre neurons in the DRG. This inconsistency can be
due to the sensitivity of the tdTomato reporter, which enables
detection of single Cre-active cells with high clarity or an
incomplete overlap between Grpr-Cre and Grpr expression in
adult. Tracing analysis with FG, injected into 2 major brain areas
involved in itch processing1; the LPB4,32 and VPL/VPM,2 showed
that only 2 of 203 traced projection neurons overlapped with
tdTomato;Grpr-Cre–positive cells, which indicates that they
represent interneurons. GRPR-positive neurons have previously
been suggested to be separated from projection neurons based
on the lack of overlap with NK1R,38 a receptor expressed
predominantly by projection neurons in lamina I of the dorsal horn
of the spinal cord.3,32,38 Our tracing data showed that Grpr-Cre
neurons do not extend projections outside the spinal cord and,
therefore, can be regarded as interneurons. In support, 9 of 13 of
the GRP spike responding cells were here classified as tonic
neurons, a class that has been reported as excitatory interneur-
ons,25 although tonic firing response neurons have also been
correlated with inhibitory interneurons.13,21,36
4.3. Grpr-Cre is an excitatory itch-related population
Increasing evidence has emerged for the importance of excitatory
neurons in a labeled line for itch.11,29,35 Selective ablation of
testicular orphan nuclear receptor 4 (TR4) in the central nervous
system resulted in the loss of an excitatory interneuron population
in the spinal cord dorsal horn. These transgenic animals displayed
an absence of itch, an increased mechanical threshold and
reduced pain behavior in response to noxious heat stimuli.
Interestingly, a substantial (83%) loss of Grpr could be observed
in the spinal cord of these TR4 conditional knockoutmice.35 As our
single-cell data showed that 63% of Grpr mRNA/Grpr-Cre–
expressing neurons also expresses Vglut2, it was of interest to
investigate the outcome on sensory behavior of removing
excitatory signaling, via VGLUT2, specifically from Grpr-Cre
neurons by crossing Grpr-Cre with Vglut2-lox. The analysis
revealed no differences between control and Vglut2-deficient mice
in several pain tests except for an increased threshold for
mechanical pain, which is in line with the mechanical pain
phenotype observed in TR4 conditional knockout mice, which
could suggest that an excitatory interneuron population confined
Figure 5. Grpr-Cre neurons signal using VGLUT2-mediated transmission. (A) Electrophoresis gel image showing a Vglut2-positive and negative cell, ladder 100
bp. (B-D) Grpr-Cre;Vglut2f/f responded normally to touch using von Frey filaments (n5 8, P5 0.20), to noxious cold and heat measured using tail withdrawal test
(TWT, n 5 9, P 5 0.56) and Hargreaves test (n 5 9, P 5 0.34), respectively, compared with control littermates, (E) but displayed a significant difference when
assessing noxious mechanical stimuli using Randall–Selitto (n5 7, P5 0.011). (F-G) Grpr-Cre;Vglut2f/f mice showed decreased spontaneous itch (n5 16, P5
0.044) behavior compared with littermate controls (F). Grpr-Cre;Vglut2f/f mice also displayed attenuated behavior after intradermal NaCl injection (n 5 16, P 5
0.018), attenuated itch behavior after compound 48/80 injection (10 mg, n5 7, P5 0.004) and chloroquine injection (10 mM, n5 9, P5 0.0012) (G). Insertion of
the Cre cassette had no additional effects on touch (B), thermal pain (C-D), mechanical pain (E), or spontaneous itch (F) behavior. (H) Grpr-Cre neurons infected
with AAV9/CAG-DiO-GCaMP6 in a 300 mM slice in the dorsal horn of a lumbar spinal cord section. (I) Representative trace of a Grpr-Cre–positive neuron
responding to bath application of natriuretic polypeptide B (NPPB) 40 nM with an increase of 110% in its fluorescence. *P, 0.05, **P, 0.01, Mann–Whitney 2-
tailed U test. Data described as mean 6 SEM.
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within TR4/Grpr-Cre/VGLUT2 neurons conveys mechanical pain.
It has been shown that an excitatory population in lamina II, marked
by the 2 neuropeptides; somatostatin and calretinin, is required for
mechanical pain.9,20 Possibly, a small subpopulation within Grpr-
Cre that is confined to lamina II includes one or both of these
neuropeptide populations and, hence, mediates the mechanical
phenotype displayed by the Vglut2-lox;Grpr-Cre animals.
When assessing the itch phenotype in the Vglut2-deficient mice,
decreased scratching episodes were observed compared with
controls, for both the histaminergic and the nonhistaminergic
substances. This supports previous data, inferring that GRPR
expression defines an itch-specific population,17,30,31 and we can
now conclude that the itch transmission via GRPR neurons mainly
relies on VGLUT2-mediated signaling. However, despite the evident
support for glutamate-mediated itch transmission via Grpr-Cre
neurons in the spinal cord, an additional central effect cannot be
dismissedbecauseGrpr-Cre is expressed in several brain nuclei and
removing VGLUT2-mediated signaling could consequently affect
these nuclei. Among these, thalamus, periaqueductal gray, and
parabrachial nucleus are involved in itch processing (Table 1).7,19
Several itch-specific populations have been identified recently,
adding to the increased evidence for a labeled line for itch.17,31
Neurons expressing GRPR were the first population identified as
a solely itch-transmitting population.30,31 We propose that the Grpr
population consists of excitatory interneurons that are activated by
GRP and uses VGLUT2-mediated signaling to convey chemically
induced pruritic transmission further. Whether Grpr-Cre neurons
interact directly with projection neurons or excite a hitherto unknown
itch-transmitting population needs further investigation. Previous
data have placed the GRPR population as the tertiary line in itch
transmission after itch-specific primary afferents expressing NPPB
and interneurons expressing the NPRA and GRP.17 Our analysis,
using bath-applied NPPB and calcium imaging, shows that
a potential subpopulation of Grpr-Cre neurons works downstream
of NPRA neurons, as NPPB caused calcium influx in part of AAV9/
CAG-DIO-GCaMP6–infected Grpr-Cre neurons. As NPRA and
GRPR have been shown to not colocalize in the spinal cord,12,17
these results suggest that the bath-applied NPPB was able to
activate spinalNPRAneurons that possibly expressGRP,12,17which
subsequently led to activation of Grpr-Cre cells. Our findings, thus,
allow us to place parts of the Grpr-Cre population downstream of
NPRA neurons and upstream of itch-mediating projection neurons.
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